Clinical trialCLINICALTRIALSApr 2
Researchers in France are studying a new tool called MEKANOS that measures how strong bones are and predicts fracture risk in people with fibrous dysplasia, a rare bone disease. This clinical trial involves 20 patients and aims to solve a major problem doctors face: they currently have no good way to know which patients are at highest risk of bone breaks. The study could help doctors make better treatment decisions for this condition.
WHY IT MATTERSThis trial addresses a critical gap in fibrous dysplasia care—doctors currently lack reliable tools to predict which patients will experience fractures, making this the first systematic assessment of fracture risk in this population.
ResearchPUBMEDApr 1
Scientists are developing a new way to study rare bone diseases using lab-grown bone tissue called organoids. Instead of only using animal tests or simple cell cultures, researchers can now grow tiny bone structures that act like real bones. This helps them understand why these diseases happen and test new treatments more accurately before trying them in patients.
WHY IT MATTERSFor patients with rare skeletal disorders, bone organoids could speed up the discovery of treatments by allowing researchers to test drugs on disease-specific bone tissue grown from patient cells, potentially leading to personalized medicine approaches.
Clinical trialCLINICALTRIALSMar 26
Researchers are testing a new way to help young people with rare bone diseases get better. The program combines sailing therapy (being out on the water) with online rehabilitation exercises that patients can do at home. This study builds on earlier successful results and will compare two different treatment approaches to see which works best.
WHY IT MATTERSThis trial offers young patients with rare skeletal disorders access to an innovative rehabilitation model combining in-person sailing therapy with remote maintenance care, potentially improving outcomes beyond traditional therapy alone.